Contribution: Industrial Research Assistance Program – Contributions to Firms
Zilia inc.
$75,000.00
ARP - Feasibility - Artificial Eye Development for Ocular Biomarker Assessment
EF 2023-24 · 2023-04-01
Résumé
The association of ocular biomarkers with systemic health and disease ("Oculomics") is rapidly developing. It offers a unique opportunity to deepen the understanding of eye-body relationships and to support the development of new diagnostic tools by non-invasive means. The creation of in vitro and digital artificial eye models would accelerate the development of blood biomarker applications. Such platforms provide an innovative avenue for future breakthroughs related to the development of new biomarkers associated with ocular and general health conditions.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Quebec|Québec, Quebec, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
819510900
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2023-04-01 | 2023-24 | $75,000.00 |
| 1 | 2023-04-01 | 2023-24 | $75,000.00 |
| 2 | 2023-04-01 | 2023-24 | $75,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 60 jours.
Agreement End Date
2024-03-31
Agreement Number
1003718
Agreement Start Date
2023-04-01
Agreement Title
ARP - Feasibility - Artificial Eye Development for Ocular Biomarker Assessment
Agreement Title (French)
PRA - Faisabilité - Développement d’œil artificiel pour l’évaluation de biomarqueurs oculaires.
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Date
2023-12-21
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The association of ocular biomarkers with systemic health and disease ("Oculomics") is rapidly developing. It offers a unique opportunity to deepen the understanding of eye-body relationships and to support the development of new diagnostic tools by non-invasive means. The creation of in vitro and digital artificial eye models would accelerate the development of blood biomarker applications. Such platforms provide an innovative avenue for future breakthroughs related to the development of new biomarkers associated with ocular and general health conditions.
Description (French)
L'association de biomarqueurs oculaires avec la santé et les maladies systémiques (“Oculomics”) est en développement rapide. Elle offre une occasion unique d'approfondir la compréhension des relations œil-corps et de soutenir le développement de nouveaux outils de diagnostic par des moyens non invasifs.
La création de modèles d’œil artificiel in vitro et digitaux permettrait l’accélération du développement d’applications liées aux biomarqueurs sanguins. De telles plateformes fournissent une avenue novatrice pour les prochaines percées reliées au développement de nouveaux biomarqueurs associées à des conditions de santé oculaire et générale.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Québec
Federal Riding (French)
Québec
Federal Riding Number
24059
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
819510900
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Zilia inc.
Recipient Postal Code
G1K 3G5
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2022-2023-Q4-1003718
